SOPHiA GENETICS SA
SOPH
$3.18
-$0.02-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.32M | 17.78M | 17.73M | 15.85M | 15.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.32M | 17.78M | 17.73M | 15.85M | 15.81M |
| Cost of Revenue | 6.05M | 5.57M | 5.63M | 5.20M | 5.03M |
| Gross Profit | 12.27M | 12.21M | 12.10M | 10.65M | 10.78M |
| SG&A Expenses | 22.34M | 19.13M | 20.52M | 18.19M | 17.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -66.00K | -8.00K | -116.00K | -43.00K | -18.00K |
| Total Operating Expenses | 36.82M | 33.82M | 35.18M | 31.22M | 30.81M |
| Operating Income | -18.49M | -16.04M | -17.44M | -15.36M | -15.01M |
| Income Before Tax | -21.65M | -16.88M | -14.54M | -18.31M | -15.03M |
| Income Tax Expenses | 762.00K | 503.00K | 616.00K | 130.00K | 161.00K |
| Earnings from Continuing Operations | -22.41M | -17.39M | -15.16M | -18.44M | -15.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.41M | -17.39M | -15.16M | -18.44M | -15.19M |
| EBIT | -18.49M | -16.04M | -17.44M | -15.36M | -15.01M |
| EBITDA | -17.48M | -14.98M | -16.96M | -14.09M | -13.76M |
| EPS Basic | -0.33 | -0.26 | -0.23 | -0.28 | -0.23 |
| Normalized Basic EPS | -0.20 | -0.16 | -0.14 | -0.17 | -0.14 |
| EPS Diluted | -0.33 | -0.26 | -0.23 | -0.28 | -0.23 |
| Normalized Diluted EPS | -0.20 | -0.16 | -0.14 | -0.17 | -0.14 |
| Average Basic Shares Outstanding | 67.32M | 66.84M | 65.90M | 66.38M | 65.92M |
| Average Diluted Shares Outstanding | 67.32M | 66.84M | 65.90M | 66.38M | 65.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |